Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system. The Mayo Clinic says MS causes the breakdown of the protective covering of nerve fibers, known as ...

Both MS and fibromyalgia may cause chronic ... Before you begin any tests, you may be able to distinguish your symptoms and decide if they’re signs of one of these conditions.

Early signs of multiple sclerosis could soon be detected by a simple blood test years before symptoms start to show. American ...

This causes damage that disrupts nerve signals, leading to a variety of symptoms. MS symptoms usually first appear in young adulthood, with MS being three times more common in females than in males.

Relapsing MS is the most common form of multiple sclerosis ... but rapidly over usually a couple of days. Typical symptoms for a relapse could actually be any part of your brain not working ...

Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...

The symptoms of MS can vary widely, depending on the nerves that are affected. Learn more about the risk factors, symptoms, and treatment options. Signs and Symptoms of Multiple Sclerosis in ...

As you learn more about they type of MS you have, you'll have a clearer idea how it may affect you in the coming years. Many other conditions have symptoms similar to those of MS. Your doctor will ...

Medscape Medical News, March 14, 2024 Fast Five Quiz: Multiple Sclerosis Signs and Symptoms Do you know the signs and symptoms of multiple sclerosis? Check your knowledge with this quick quiz.

Most people are happy to repeat what you’ve said. Speech problems usually come about as a result of other symptoms caused by MS, such as decreased coordination, fatigue, and muscle weakness.

Some people with MS may have only mild symptoms, while others may lose their ability to see clearly, write, speak, or walk. It can cause muscle weakness, pain, difficulty balancing, numbness ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.